Search Results 211-220 of 1297 for Ultane

1. Study of Orally Administered AG-120 in Subjects with Advanced Hematologic Malignancies with an IDH1 Mutation - Mayo Clinic

   About this study. The purpose of this Phase I, multicenter study is to evaluate the safety, pharmacokinetics, pharmacodynamics and clinical activity of ...

2. Ustekinumab-kfce (intravenous route, subcutaneous route) - Mayo Clinic

   Ustekinumab-kfce injection is used to treat moderate to severe plaque psoriasis in patients who may benefit from receiving phototherapy (ultraviolet light ...

3. Drugs and Supplements that Start with A - Mayo Clinic

   Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “A” to learn about drug side effects, proper use and ...

4. Olutasidenib (oral route) - Side effects & dosage - Mayo Clinic

   Olutasidenib is used to treat acute myeloid leukemia in patients with a susceptible isocitrate dehydrogenase-1 (IDH-1) mutation that has come back or has not ...

5. Nephrology and Hypertension - Clinical trials

   Rochester, Minn. The overall objective of this study is to define genes causing cystic kidney disease and to determine the degree to which variants at these ...

6. (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive - Mayo Clinic

   (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive. Print ...

7. Immune thrombocytopenia (ITP) - Doctors and departments - Mayo Clinic

   Caused by low levels of platelets, symptoms may include purple bruises called purpura, as well as tiny reddish-purple dots that look like a rash.

8. MRI Study To Identify Functional and Structural Changes That Correlate with Patient Improvement When Imaging the Brain Pre-and-Post Erenumab - Mayo Clinic

   The purpose of this study is to identify changes in brain function and structure that correlate with response to erenumab, and to develop models using imaging ...

9. A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BIIB078 in Amyotrophic Lateral Sclerosis (ALS) Patients - Mayo Clinic

   The secondary objective is to evaluate the pharmacokinectics or movement of drug throughout the body (PK) of BIIB078 in participants with C9ORF72-ALS.

10. Clinical trials - Oncology (Medical)

    Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.